Journey Medical Corp (DERM) Operating income 2020–2025
Journey Medical Corp (DERM) annual operating income history from SEC filings — each fiscal year as reported.
-$8.2MFY2025 · since FY2020: $7.9M → -$8.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.2M | +40.3% |
| FY2024 | -$13.7M | -559.8% |
| FY2023 | -$2.1M | +92.5% |
| FY2022 | -$27.5M | +21.1% |
| FY2021 | -$34.9M | -544.3% |
| FY2020 | $7.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DERM financial trends
DERM RevenueDERM Net incomeDERM Net marginDERM Gross profitDERM Gross marginDERM Operating marginDERM Operating cash flowDERM Free cash flowDERM Capital expendituresDERM Return on equityDERM Stock buybacksDERM Dividends paidDERM Total assetsDERM Total liabilitiesDERM Shareholders’ equityDERM overview →